Literature DB >> 1291314

Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991.

J Reina1, N Borrell, A Serra.   

Abstract

During the period 1987 to 1991 a retrospective study was performed to determine the resistance of thermotolerant Campylobacter species isolated from feces to erythromycin and fluoroquinolones. Of the 672 strains studied, 614 (91.3%) were identified as Campylobacter jejuni and 58 (8.7%) as Campylobacter coli. During the study period the rate of resistance of Campylobacter jejuni to erythromycin remained relatively stable (0.9-3.5%), while resistance of Campylobacter coli to erythromycin emerged later (1989) with much higher rates (14.8-33%). Overall, 11.8% and 10.7% of Campylobacter jejuni strains isolated after 1987 were resistant to nalidixic acid and ciprofloxacin respectively, resistance increasing from 2.3% in 1988 to 32% in 1991. In 1991 the first strains of Campylobacter coli with resistance to these fluoroquinolones were detected (rates 29% and 26% respectively). Of the strains resistant to nalidixic acid, only 10.9% were susceptible to ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1291314     DOI: 10.1007/bf01961137

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Fluoroquinolone-resistance in thermophilic Campylobacter spp isolated from stools of Spanish patients.

Authors:  J Reina; P Alomar
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

2.  Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products.

Authors:  H P Endtz; R P Mouton; T van der Reyden; G J Ruijs; M Biever; B van Klingeren
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

3.  [Isolation of nalidixic acid resistant Campylobacter jejuni].

Authors:  J Reina; I Blanco; A Català; P Alomar
Journal:  Enferm Infecc Microbiol Clin       Date:  1989-05       Impact factor: 1.731

4.  Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

Authors:  H P Endtz; G J Ruijs; B van Klingeren; W H Jansen; T van der Reyden; R P Mouton
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

5.  Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.

Authors:  M Altwegg; A Burnens; J Zollinger-Iten; J L Penner
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

6.  Erythromycin-resistant campylobacters.

Authors:  W A Brunton; A M Wilson; R M Macrae
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

7.  Incidence of antibiotic resistance and characterization of plasmids in Campylobacter jejuni strains isolated from clinical sources in Alberta, Canada.

Authors:  D E Taylor; N Chang; R S Garner; R Sherburne; L Mueller
Journal:  Can J Microbiol       Date:  1986-01       Impact factor: 2.419

8.  A demographic survey of campylobacter, salmonella and shigella infections in England. A Public Health Laboratory Service Survey.

Authors:  M B Skirrow
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

9.  Treatment of Campylobacter-associated enteritis with erythromycin.

Authors:  R M Robins-Browne; M K Mackenjee; M N Bodasing; H M Coovadia
Journal:  Am J Dis Child       Date:  1983-03

10.  Erythromycin-resistant Campylobacter infections in Thailand.

Authors:  D N Taylor; M J Blaser; P Echeverria; C Pitarangsi; L Bodhidatta; W L Wang
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

View more
  17 in total

1.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.

Authors:  Frédéric Poly; Timothy D Read; Yu-Han Chen; Mario A Monteiro; Oralak Serichantalergs; Piyarat Pootong; Ladaporn Bodhidatta; Carl J Mason; David Rockabrand; Shahida Baqar; Chad K Porter; David Tribble; Michael Darsley; Patricia Guerry
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

3.  Evaluation of the API-campy system in the biochemical identification of hippurate negative campylobacter strains isolated from faeces.

Authors:  J Reina; M J Ros; A Serra
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

4.  gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing.

Authors:  Antti Hakanen; Jari Jalava; Pirkko Kotilainen; Hannele Jousimies-Somer; Anja Siitonen; Pentti Huovinen
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis.

Authors:  M L Hänninen; S Pajarre; M L Klossner; H Rautelin
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

6.  Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.

Authors:  C Dupeyron; N Mangeney; L Sedrati; B Campillo; P Fouet; G Leluan
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

8.  Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients.

Authors:  J Reina; M J Ros; A Serra
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

9.  High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases.

Authors:  A Gibreel; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.

Authors:  J L Gomez-Garces; R Cogollos; J L Alos
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.